Find Your Treatment Option See if prescription weight-loss treatment may be right for you
The Medicare GLP-1 Bridge is a federal CMS program that started July 1, 2026, providing eligible Part D enrollees including Humana MAPD members access to Foundayo, Wegovy, or Zepbound at $50 per 30-day supply
It is a good fit for those times when you want the same product direction as the full size, but in a more practical mini version for trying it first, for travel, or as a smaller step in your routine without unnecessary uncertainty
Note that GLP-1 receptor agonists like Rybelsus have a low risk of causing hypoglycaemia when used alone
Additional Benefits of Semaglutide Semaglutide provides a range of metabolic, cardiovascular, and weight management benefits, making it an essential therapy for physician-directed treatment plans
Over the following months, new collagen and elastin are produced, firming and lifting the skin from within